Skip to main content
. 2023 Jan 31;30(4):173–185. doi: 10.32604/or.2022.027262

Table 5. Survival probability of lung cancer incident cases by survival time, sex, age group and year of diagnosis.

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
5-year survival
Total (+) 19.0 18.6 18.9 19.7 18.8 19.8 19.7
Sex
Men (+) 14.9 15.6 15.2 16.9 15.4 16.7 17.9
Women (−) 24.2 22.5 23.4 23.2 22.9 23.4 21.9
Age group
18–35 (−) 71.4 75.0 88.9 62.5 52.4 68.8 56.2
35–50 (+) 28.3 27.7 29.6 28.9 30.9 32.8 38.6
50–65 22.0 22.4 22.9 24.6 22.4 24.4 22.2
65–80 (+) 18.5 18.0 17.9 19.2 18.5 18.6 20.1
80+ (−) 8.3 6.6 8.5 7.0 7.2 8.4 6.6
3-year survival
Total (+) 24.4 24.7 25.3 26.1 25.4 26.7 26.2 26.9 27.8
Sex
Men (+) 20.5 21.2 21.1 22.8 22.1 23.7 24.0 23.5 23.9
Women (+) 29.3 29.2 30.5 30.2 29.5 30.1 28.9 30.8 32.1
Age group
18–35 71.4 75.0 88.9 62.5 57.1 68.8 56.2 80.0 66.7
5-50 (+) 33.2 33.2 34.9 34.0 37.5 38.2 41.7 45.0 47.5
50–65 27.2 28.5 29.6 30.2 28.3 31.0 28.9 29.3 31.3
65–80 (+) 24.3 24.7 24.4 26.1 25.7 26.0 26.9 27.5 27.5
80+ 12.8 10.8 14.8 14.1 13.8 15.2 12.7 13.9 13.9
1-year survival
Total (+) 48.5 48.6 48.8 49.9 49.3 50.5 49.5 50.7 51.4 50.6 51.2
Sex
Men 45.0 45.2 45.0 45.7 46.0 47.5 47.1 47.6 48.1 46.1 48.1
Women 53.0 52.7 53.6 55.1 53.4 53.9 52.3 54.3 55.1 55.5 54.4
Age group
18–35 92.9 83.3 88.9 93.8 85.7 75.0 75.0 80.0 83.3 90.0 72.7
35–50 60.6 60.2 54.5 59.5 64.7 62.2 62.6 69.0 67.7 59.1 69.9
50–65 (+) 51.8 53.5 55.0 53.9 55.2 55.9 55.1 55.0 56.1 57.0 56.6
65–80 (+) 49.4 49.2 48.1 50.6 49.2 50.5 49.5 50.8 51.4 51.0 51.0
80+ (+) 31.1 28.6 35.2 34.8 31.5 33.5 32.5 35.1 35.0 34.2 36.1
6-month survival
Total 67.5 67.0 67.3 68.3 67.2 68.1 67.4 68.1 68.1 68.4 67.4
Sex
Men 65.7 64.5 64.5 65.2 65.1 65.7 66.2 66.8 65.7 64.7 65.2
Women 69.9 70.3 70.8 72.1 69.8 70.8 68.8 69.5 70.8 72.4 69.7
Age group
18–35 100.0 100.0 88.9 93.8 95.2 93.8 87.5 100.0 88.9 100.0 90.9
35–50 77.5 78.9 76.4 80.8 79.3 80.7 80.7 83.7 82.5 79.0 82.1
50–65 (+) 73.0 72.9 72.4 73.9 73.3 74.1 73.6 74.2 73.6 76.1 72.6
65–80 67.5 66.9 67.8 67.9 67.6 67.9 67.2 67.7 68.2 68.2 67.4
80+ 49.3 47.4 51.1 53.2 48.7 50.3 50.3 51.1 49.9 50.9 52.8
3-month survival
Total 0.81 0.81 0.81 0.81 0.81 0.81 0.81 0.81 0.82 0.81 0.81
Sex
Men 0.80 0.79 0.79 0.79 0.80 0.80 0.80 0.80 0.81 0.79 0.80
Women 0.82 0.84 0.84 0.84 0.82 0.83 0.82 0.82 0.84 0.84 0.82
Age group
18–35 1.00 1.00 1.00 1.00 1.00 0.94 1.00 1.00 0.94 1.00 1.00
35–50 0.87 0.89 0.88 0.91 0.91 0.92 0.89 0.93 0.92 0.89 0.92
50–65 (+) 0.85 0.86 0.84 0.86 0.86 0.85 0.85 0.85 0.87 0.87 0.85
65–80 0.82 0.81 0.81 0.81 0.81 0.81 0.81 0.81 0.82 0.81 0.80
80+ (+) 0.65 0.67 0.71 0.70 0.67 0.70 0.69 0.70 0.70 0.68 0.72

Note: If the three year average is always higher (lower) than the three year average of the period immediately before, the trend is labeled as increased (decreasing). An increasing trend in survival is denoted by (+), a decreasing trend by (−).